Vijaya Diagnostic Centre Limited — Investor Meet, 19-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Vijaya Diagnostic delivered record Q3 FY26 revenue of ₹205 Cr (+21.4% YoY), fueled by 14.7% volume growth. EBITDA rose 28.2% to ₹86 Cr, achieving 41.9% margins, with net profit up 22.3% to ₹43 Cr. The core Hyderabad market grew organically by 15% YoY. New West Bengal hubs broke even ahead of schedule, highlighting strong demand. Management plans to add 4-5 hubs and 10-12 spokes in FY27, with a capex of ₹100-120 Cr, backed by a ₹260 Cr net cash surplus. The wellness segment shows robust and continued growth.